[EN] HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF [FR] INHIBITEURS D'HISTONE DÉSACÉTYLASE, ET COMPOSITIONS ET MÉTHODES D'UTILISATION DE CEUX-CI
Histone deacetylase inhibitors and compositions and methods of use thereof
申请人:CHDI Foundation, Inc.
公开号:US10065948B2
公开(公告)日:2018-09-04
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of their use. The condition or disorder mediated by HDAC comprises a neurodegenerative pathology. Accordingly, also provided is a method of treating a neurodegenerative pathology mediated by HDAC in a subject in need of such a treatment, comprising administering to the subject a therapeutically effective amount of at least one compound, or pharmaceutically acceptable salt thereof, described herein.
本文提供了某些式 I 的组蛋白去乙酰化酶(HDAC)抑制剂或其药学上可接受的盐、其组合物及其使用方法。由 HDAC 介导的病症或紊乱包括神经退行性病理学。因此,还提供了一种在需要治疗的受试者中治疗由HDAC介导的神经退行性病理的方法,包括向受试者施用治疗有效量的至少一种本文所述的化合物或其药学上可接受的盐。
Aminoesters of Substituted Alicylic Carboxylic Acids<sup>1</sup>
作者:Charles H. Tilford、M. G. van Campen、Robert S. Shelton
DOI:10.1021/ja01203a077
日期:1947.11
HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
申请人:CHDI Foundation, Inc.
公开号:EP3148539A1
公开(公告)日:2017-04-05
US4873241A
申请人:——
公开号:US4873241A
公开(公告)日:1989-10-10
[EN] HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS D'HISTONE DÉSACÉTYLASE, ET COMPOSITIONS ET MÉTHODES D'UTILISATION DE CEUX-CI